2.5mg Mounjaro not working: what's actually happening

The first pen's job is adjustment, not results

Mounjaro is a dual GIP and GLP-1 receptor agonist. It works by acting on two gut-hormone pathways simultaneously, slowing gastric emptying, reducing appetite and influencing how your body handles blood sugar. At full therapeutic doses, that dual action is powerful enough that SURMOUNT-1 (one of the largest obesity trials ever conducted) recorded average weight reductions of around 20% over 72 weeks at 15mg, as published in the New England Journal of Medicine. But those results came at the end of a long titration, not the beginning.

The 2.5mg starting strength is, in practical terms, a settling-in period. Your prescriber prescribes it first because jumping straight to a higher dose dramatically increases the risk of nausea, vomiting and other gastrointestinal side effects. Spending four weeks at 2.5mg is not four wasted weeks, it is the foundation that makes the rest of the treatment tolerable and sustainable. Many people at this stage report no change in appetite and no change on the scales. That is expected. It is the reason the next dose exists.

On a more human note: the timing can feel especially deflating if your first pen arrived just before a holiday or a run of busy weeks and you were hoping to see early signs of progress. The biology simply doesn't hurry for the calendar. Give the process the full four weeks before drawing any conclusions about whether the medicine is working for you.

What changes (and what doesn't) as you move up through the doses

Once your prescriber increases your dose to 5mg, and then progressively toward 7.5mg, 10mg, 12.5mg and eventually 15mg (where clinically appropriate), the picture usually changes considerably. Appetite suppression becomes noticeable, gastric emptying slows more significantly and most people find eating smaller portions feels natural rather than forced. The titration schedule is typically in four-week steps, though your prescriber will assess how you're tolerating each level before recommending any increase.

It's worth understanding that individual response does vary. Some people feel a marked shift in hunger quite early in the process; others reach higher doses before anything feels different. Neither pattern is a failure. For anyone wondering about the experience at the next stage, our guide to what happens if 5mg Mounjaro doesn't seem to be working covers exactly that ground. If you've already moved beyond 5mg, the same question is addressed for 7.5mg and higher doses further along the titration pathway, including our guidance on what to do if 10mg Mounjaro doesn't seem to be making a difference and a closer look at why 12.5mg Mounjaro may feel like it isn't working yet.

The key point here: progress at 2.5mg is not the measure. Progress over the full titration is. Judging the medicine at its lowest dose is a little like judging a car's top speed from a standing start in first gear.

When to speak to your prescriber rather than wait

There is a meaningful difference between the normal experience of seeing little change at 2.5mg and something that genuinely needs clinical attention. If you are struggling with side effects that feel unmanageable (persistent nausea, vomiting, diarrhoea or stomach pain) your prescriber should know. The same applies if you have developed a new health condition since your consultation, or if you're taking a new medicine that may interact with tirzepatide. Women on oral contraceptives should be aware that tirzepatide can reduce pill absorption during the first four weeks of treatment and after each dose increase, as noted in NHS England's guidance on weight management injections, a barrier method alongside is recommended during those periods.

If you're wondering whether cost is a barrier to continuing (whether staying the course at the right dose is financially realistic) the Mounjaro pricing page sets out the honest picture of what private treatment involves. That might be a useful read before your next prescription review.

A prescriber review before changing anything yourself is always the right call. That includes decisions about delaying a dose increase, stopping treatment early or switching. Our clinical team reviews every repeat prescription individually (it's never automated) so these conversations happen as a matter of course. If you'd prefer to raise a concern directly, our support team is available seven days a week.

The broader decision: continue, escalate, or review the whole picture

At 2.5mg Mounjaro not working is really a prompt to clarify your goal, not to abandon treatment. The options are straightforward. Continue to the next dose as scheduled, trusting that the titration is designed around where results actually emerge. Request a prescriber review if something feels wrong or unmanageable. Or, if you have broader questions about whether tirzepatide is the right route for you at all, a fresh consultation is a good reset point.

Mounjaro is a prescription-only medicine, which means every dose decision requires clinical input, that's not a bureaucratic inconvenience, it's how the treatment is kept safe. For context on the full treatment, our Mounjaro overview explains the licensed indication, how titration works across the full dose range and what the evidence says about longer-term outcomes. Our broader weight-loss treatment page covers the alternative options too, if the conversation with your prescriber opens up that question.

The short version: 2.5mg not working is not a sign that Mounjaro won't work for you. It's a sign that you're at the beginning of the process, which is exactly where you should be.